Therapeutic targeting of the DNA mismatch repair pathway

SA Martin, CJ Lord, A Ashworth - Clinical cancer research, 2010 - AACR
The mismatch repair (MMR) pathway is involved in the removal of DNA base mismatches
that arise either during DNA replication or are caused by DNA damage. Mutations in four …

DNA mismatch repair and the DNA damage response to ionizing radiation: making sense of apparently conflicting data

LM Martin, B Marples, M Coffey, M Lawler… - Cancer treatment …, 2010 - Elsevier
The DNA mismatch repair (MMR) pathway detects and repairs DNA replication errors. While
DNA MMR-proficiency is known to play a key role in the sensitivity to a number of DNA …

Up-regulation of mismatch repair genes MSH6, PMS2 and MLH1 parallels development of genetic instability and is linked to tumor aggressiveness and early PSA …

W Wilczak, S Rashed, C Hube-Magg, M Kluth… - …, 2017 - academic.oup.com
DNA mismatch repair (MMR) is integral to the maintenance of genetic stability. We aimed to
evaluate the clinical impact of MMR gene expression in prostate cancer. The MMR genes …

Expressional analysis of MLH1 and MSH2 in breast cancer

SS Malik, N Masood, M Asif, P Ahmed, ZU Shah… - Current Problems in …, 2019 - Elsevier
Background Mismatch repair proteins are ubiquitous keys in diverse cellular functions and
protects the genome by correcting mismatch as post replication error correction machinery …

Deregulated estrogen receptor signaling and DNA damage response in breast tumorigenesis

A Rajan, R Nadhan, NR Latha, N Krishnan… - … et Biophysica Acta (BBA …, 2021 - Elsevier
Carriers of BRCA1 mutations have a higher chance of developing cancers in hormone-
responsive tissues like the breast, ovary and prostate, compared to other tissues. These …

[HTML][HTML] Why one-size-fits-all vaso-modulatory interventions fail to control glioma invasion: in silico insights

JCL Alfonso, A Köhn-Luque, T Stylianopoulos… - Scientific reports, 2016 - nature.com
Gliomas are highly invasive brain tumours characterised by poor prognosis and limited
response to therapy. There is an ongoing debate on the therapeutic potential of vaso …

[HTML][HTML] Effect of ubiquitin protease system on DNA damage response in prostate cancer

Y Lin, X Jin - Experimental and Therapeutic Medicine, 2024 - spandidos-publications.com
Genomic instability is an essential hallmark of cancer, and cellular DNA damage response
(DDR) defects drive tumorigenesis by disrupting genomic stability. Several studies have …

DNA demethylation by 5-aza-2-deoxycytidine treatment abrogates 17 beta-estradiol-induced cell growth and restores expression of DNA repair genes in human …

KP Singh, J Treas, T Tyagi, W Gao - Cancer letters, 2012 - Elsevier
Prolonged exposure to elevated levels of estrogen is a risk factor for breast cancer. Though
increased cell growth and loss of DNA repair capacity is one of the proposed mechanisms …

[HTML][HTML] The impact of HER2-low status on response to neoadjuvant chemotherapy in clinically HER2-negative breast cancer

W Wang, T Zhu, H Chen, Y Yao - Clinical and Translational Oncology, 2023 - Springer
Purpose Low expression of HER2 (HER2-low expression) in breast cancer (BC) has unique
biological characteristics. However, whether HER2-low expression has an impact on …

[HTML][HTML] The convergence of DNA damage checkpoint pathways and androgen receptor signaling in prostate cancer

HQ Ta, D Gioeli - Endocrine-related cancer, 2014 - erc.bioscientifica.com
It is increasingly clear that castration-resistant prostate cancer (PCa) is dependent on the
androgen receptor (AR). This has led to the use of anti-androgen therapies that reduce …